Shandong Sino-Agri United Biotechnology Co Ltd (003042) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Shandong Sino-Agri United Biotechnology Co Ltd stock ¥6.44, price ¥12.40, that is 48.1% below the price, quality 36 out of 100. Rating: strongly overvalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range ¥10.75 – ¥34.83 · fair‑value band ¥2.64 – ¥10.24 · the ¥12.40 price screens above the ¥6.44 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Shandong Sino-Agri United Biotechnology Co in your weekly email
Every Wednesday you see whether Shandong Sino-Agri United Biotechnology Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. The company's products include imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides.
Show moreShow less
It also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. Shandong Sino-Agri United Biotechnology Co.,Ltd was founded in 2006 and is based in Jinan, China.
Stock analysis
Shandong Sino-Agri United Biotechnology Co Ltd (003042) currently trades at ¥12.40, while our model-based Fair Value estimate is ¥6.44, 48% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the data coverage at low.
Scenario range: ¥2.64 (bear) to ¥10.24 (bull), the price of ¥12.40 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Shandong Sino-Agri United Biotechnology Co Ltd reported revenue of 1.9B CNY in FY2025 versus 1.6B CNY in FY2021, a compound +3.4%/yr. Reported net income was −137M CNY in FY2025.
Key figures
Market cap 1.8B CNY (≈ $265M) Micro · P/S ratio 0.93 · EPS (TTM) ¥−1.28 · Dividend yield 1.1% · Net margin −9.4% · Return on equity −14.3% · Return on assets (EBIT) −1.5% (5-year average) · Operating margin −9.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 51% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at 4% fair-value upside, at −48%, 003042 screens richer than that median.
Fair Value models
Bear¥2.64Fair Value ¥6.44Bull¥10.24
Price ¥12.40 · Downside -48.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EV/EBITDA¥1.32¥3.22¥5.1263
NCAV (Graham)¥3.67¥4.92¥7.3554
All 2 models by family
Multiples
EV/EBITDA¥1.32¥3.22¥5.1263
Asset-Based
NCAV (Graham)¥3.67¥4.92¥7.3554
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.13/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−7.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.5%
Start year 2020 (pandemic). Over 10 years: +7.4% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.6% (2020) → −5.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Shandong Sino-Agri United Biotechnology Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 162 stocks
Beats the industry median on 1/11 measures
Overall it trails its industry peers.
Valuation
Quality Score36 · Bottom 25%
Fair Value upside−48.1% · Bottom 25%
Profitability
Return on assets−3.6% · Bottom 25%
Net margin (12 months)−9.4% · Bottom 25%
Operating margin (12 months)−9.7% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−7.6% · Below median
Dividend yield (12 months)1.1% · Below median
Balance sheet
Debt / equity0.12× · Above median
Valuation Multiplesvs Agricultural Inputs median · lower = cheaper
P/B1.45× · Pricier than median
P/S (12 months)0.91× · Cheaper than median
EV/EBITDA25.3× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 19
FUTURE (revenue growth)0· sector 17
PAST (return on equity)0· sector 29
HEALTH (low debt)94· sector 98
DIVIDEND (yield)22· sector 40
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shandong Sino-Agri United Biotechnology Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/003042
Frequently asked questions
Is Shandong Sino-Agri United Biotechnology Co Ltd (003042) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of ¥6.44 versus a price of ¥12.40, about 48% lower (overvalued).
What is the fair value of 003042?
Our model-based fair value for Shandong Sino-Agri United Biotechnology Co Ltd is ¥6.44 (as of Nov 8, 2026), built from audited fundamentals. The current price: ¥12.40.
What is the quality score of 003042?
Shandong Sino-Agri United Biotechnology Co Ltd has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Our model-based price target is the fair value of ¥6.44 (as of Nov 8, 2026) from 2 valuation models. Cautious scenario ¥2.64, optimistic scenario ¥10.24. It is a calculation from audited fundamentals, not an analyst target.
What is the Shandong Sino-Agri United Biotechnology Co Ltd stock forecast for 2026?
Our models put fair value at ¥6.44, about 48% lower versus a price of ¥12.40 (overvalued). Cautious scenario ¥2.64, optimistic scenario ¥10.24. The calculation is refreshed regularly with new filings.
What is the revenue of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Shandong Sino-Agri United Biotechnology Co Ltd reported trailing-twelve-month revenue of about 1.9B CNY (latest available figure, as of Nov 8, 2026).
Does Shandong Sino-Agri United Biotechnology Co Ltd pay a dividend?
Shandong Sino-Agri United Biotechnology Co Ltd currently shows a dividend yield of 1.12% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Shandong Sino-Agri United Biotechnology Co Ltd has a dividend yield of 1.1%.
What is the intrinsic value of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shandong Sino-Agri United Biotechnology Co Ltd it is ¥6.44 per share (as of Nov 8, 2026), against a price of ¥12.40. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is Shandong Sino-Agri United Biotechnology Co Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 003042 trades above its calculated fair value: price ¥12.40, fair value ¥6.44, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 003042?
No. The price is what the market pays today (¥12.40); the fair value is what the company's own numbers justify (¥6.44). For Shandong Sino-Agri United Biotechnology Co Ltd the two are ¥5.96 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shandong Sino-Agri United Biotechnology Co Ltd worth?
The market values Shandong Sino-Agri United Biotechnology Co Ltd at about 1.8B CNY (market capitalisation, as of Nov 8, 2026). Per share that is ¥12.40; our models calculate a fair value of ¥6.44 per share.
What do the bullish and bearish scenarios say about 003042?
Our models span a range for Shandong Sino-Agri United Biotechnology Co Ltd: cautious scenario ¥2.64, base ¥6.44, optimistic ¥10.24 per share (as of Nov 8, 2026, price ¥12.40). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Balance-sheet figures for Shandong Sino-Agri United Biotechnology Co Ltd (as of Nov 8, 2026): return on equity −14.3%, debt of 0.12 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 003042 from its 52-week high?
Shandong Sino-Agri United Biotechnology Co Ltd trades at ¥12.40, about 51% below its 52-week high of ¥25.41 and 9% above the low of ¥11.37 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥6.44 is for.
Which stocks are comparable to Shandong Sino-Agri United Biotechnology Co Ltd?
From the same area (Basic Materials) we also value Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, Yara International ASA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shandong Sino-Agri United Biotechnology Co Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price ¥12.40, calculated fair value ¥6.44 (−48%), Quality Score 36/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 003042 calculated?
We run Shandong Sino-Agri United Biotechnology Co Ltd through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of ¥6.44 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Shandong Sino-Agri United Biotechnology Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The closing price on Nov 6, 2026 was ¥12.40. Our model-based fair value is ¥6.44, about 48% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shandong Sino-Agri United Biotechnology Co Ltd right now?
The price sits above even our optimistic bull case (¥10.24). The favourable scenario is already priced in. Weak quality (36/100) and above fair value at the same time, the margin of safety is missing on both counts. The model range is unusually wide (¥2.64 to ¥10.24). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Shandong Sino-Agri United Biotechnology Co Ltd
How large is the market capitalisation of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The market capitalisation of Shandong Sino-Agri United Biotechnology Co Ltd is 1.8B CNY (≈ $265M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The price-to-sales ratio of Shandong Sino-Agri United Biotechnology Co Ltd is 0.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Earnings per share at Shandong Sino-Agri United Biotechnology Co Ltd are ¥−1.28. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The dividend yield of Shandong Sino-Agri United Biotechnology Co Ltd is 1.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The net margin of Shandong Sino-Agri United Biotechnology Co Ltd is −9.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The return on equity (ROE) of Shandong Sino-Agri United Biotechnology Co Ltd is −14.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
On an EBIT basis the return on assets of Shandong Sino-Agri United Biotechnology Co Ltd is −1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
The operating margin of Shandong Sino-Agri United Biotechnology Co Ltd is −9.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Revenue at Shandong Sino-Agri United Biotechnology Co Ltd is growing −7.6% versus a year earlier (3y avg −1.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shandong Sino-Agri United Biotechnology Co Ltd (003042)?
Earnings per share at Shandong Sino-Agri United Biotechnology Co Ltd are growing −66.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Shandong Sino-Agri United Biotechnology Co Ltd (003042) generate?
The free cash flow of Shandong Sino-Agri United Biotechnology Co Ltd is −116M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Shandong Sino-Agri United Biotechnology Co Ltd (003042) carry?
The net debt of Shandong Sino-Agri United Biotechnology Co Ltd is 625M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Shandong Sino-Agri United Biotechnology Co Ltd in the live analysis
One click puts Shandong Sino-Agri United Biotechnology Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026